William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Upgrades JBT Marel Corp. (JBTM) to Outperform
-
ePayPolicy Secures Strategic Investment from LLR Partners
-
Forge Global to Present at Investor Conferences in August
-
Glassbox Secures an Investment from Poalim Equity to Expand AI-Driven Experience Analytics in Financial Services
-
William Blair Reiterates Market Perform Rating on Palantir Technologies Inc. (PLTR)
-
William Blair: 'we encourage investors to have BWXT as a core holding'
-
William Blair Reiterates Outperform Rating on SoFi Technologies (SOFI)
-
Ramaco Resources issues additional $8 million in senior notes
-
RAMACO RESOURCES, INC. ANNOUNCES EXERCISE OF UNDERWRITERS' OVER-ALLOTMENT OPTION IN CONNECTION WITH ITS SENIOR UNSECURED NOTES OFFERING
-
William Blair on Wayfair (W): 'shares could find support from valuation expansion into the high-teens range'
-
William Blair Upgrades ViaSat (VSAT) to Outperform
-
Miami International Holdings launches roadshow for 15 million share IPO
-
Miami International Holdings Announces Launch of Initial Public Offering
-
GHK Capital Partners LP Completes Acquisition of Rogers Building Solutions
-
Guggenheim Securities Expands Global Technology & Services Investment Banking Businesses
-
Guggenheim Securities Expands Global Technology & Services Investment Banking Businesses
-
Form SCHEDULE 13G/A New Fortress Energy Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Orion S.A. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Oxford Square Capital Corp. Prices Public Offering of $65 Million 7.75% Notes Due 2030
-
Wipfli secures strategic investment from New Mountain Capital to accelerate growth, innovation and client solutions
-
Larimar Therapeutics closes $69 million stock offering
-
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Ramaco Resources completes $57 million senior unsecured notes offering
-
RAMACO RESOURCES, INC. COMPLETES $57,000,000 SENIOR UNSECURED NOTES OFFERING
-
Form SCHEDULE 13G/A Stride, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Mastercard signals resilient consumer spending as profit tops estimates
-
Oxford Square Capital announces public offering of notes
-
Oxford Square Capital Corp. Announces Offering of Notes
-
Payroc Signs Definitive Agreement to Acquire BlueSnap to Expand its Global Payments Reach and Automate AR at Scale
-
Payroc Signs Definitive Agreement to Acquire BlueSnap
-
Figma prices IPO at $33 per share, to begin trading July 31
-
Figma Announces Pricing of Initial Public Offering
-
Form SCHEDULE 13G/A BBB FOODS INC Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A NEOGEN CORP Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A ZIPRECRUITER, INC. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
William Blair Downgrades CyberArk Software (CYBR) to Market Perform Following Takeover
-
Form SCHEDULE 13G/A BRINKS CO Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G GeneDx Holdings Corp. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Montrose Environmental Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A MERCURY SYSTEMS INC Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Seminal Merger: Bett and GSV Summit Combine Forces to Redefine Global EdTech
-
Greenix Joins Forces with Gridiron Capital to Fuel Growth
-
Verisk expands residential insurance push with $2.4 billion AccuLynx deal
-
Verisk to acquire AccuLynx for $2.35 billion in cash
-
Verisk to acquire AccuLynx for $2.35 billion in cash deal
-
Verisk Signs Definitive Agreement to Acquire AccuLynx
-
Verisk Signs Definitive Agreement to Acquire AccuLynx
-
Larimar Therapeutics prices $60 million stock offering at $3.20 per share
-
Larimar Therapeutics Announces Pricing of Underwritten Public Offering
-
William Blair Downgrades Neogen (NEOG) to Market Perform

